ANTHEM logo

Anthem Biosciences Limited Stock Price

NSEI:ANTHEM Community·₹433.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

ANTHEM Share Price Performance

₹769.90
12.55 (1.66%)
₹769.90
12.55 (1.66%)
Price ₹769.90

ANTHEM Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Exceptional growth potential with flawless balance sheet.

0 Risks
2 Rewards

Anthem Biosciences Limited Key Details

₹20.1b

Revenue

₹7.7b

Cost of Revenue

₹12.4b

Gross Profit

₹6.6b

Other Expenses

₹5.8b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
10.23
61.66%
28.69%
1.8%
View Full Analysis

About ANTHEM

Founded
2006
Employees
2282
CEO
Ajay Bhardwaj
WebsiteView website
anthembio.com

Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients. The company offers contract research development and manufacturing services, such as end-to-end services across the new chemical entity and new biological entity lifecycles, as well as engages in contract research, development, and manufacturing of development batches of molecules used for clinical trials up to commercial manufacturing for small molecules and biologics. It also manufactures and sells specialized fermentation-based active pharmaceutical ingredients, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company was incorporated in 2006 and is based in Bengaluru, India.